Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Chitte who wrote (8783)	5/14/1998 5:45:00 PM
From: Don Westermeyer	Read Replies (1) \| Respond to of 18691

Alex, Using an option to reduce the risk of a large holding is perfectly appropriate - especially if your new to this game. The other way to reduce risk is to just own less of the stock. As far as ZITL goes, I wouldn't bother hedging unless some real positive news comes from the company. I doubt that will happen. Sometimes I'll sell deep out of the money options as a bet. For instance I might sell June $5 puts in ZITL for 1/4 thinking if the stock goes below $5 I'll probably cover anyway (at least partially). One nice thing selling a ZITL option is there is a lot of premium in the option due to its volatility. I suspect a lot of fools will buy/write ZITL at $7.50 because of the 12% premium in the call. Good luck, Don

To: Jacques Chitte who wrote (8783)	5/14/1998 9:38:00 PM
From: clochard	Read Replies (1) \| Respond to of 18691

ZONA's price can be explained by the hype going on in the press. A lot of financial reporters don't check their facts. Today the following: biz.yahoo.com "This stimulation relies on a different biological mechanism than other products developed for the treatment of male erectile dysfunction, such as the recently approved Viagra(TM) (Pfizer, Inc.) (NYSE: PFE - news) or the long-time product Vasomax(TM) (Zonagen, Inc.) (Nasdaq-SmallCap: ZONA - news). "